Back to compounds

COMPOUND PROFILE / PEPTIDES & ANALOGUES

Petrelintide.

Research draft

Petrelintide is a long-acting amylin analogue investigated for weight management.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Petrelintide is a long-acting amylin analogue investigated for weight management.

CLASSIFICATIONPeptides & analogues
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

It engages amylin-related satiety signalling.

Human research

Randomised phase 1 and phase 2 studies provide human development evidence; short-term results do not settle long-term outcomes.

Preclinical & other research

Receptor and animal work support its satiety rationale.

Safety & unknowns

Gastrointestinal effects and exposure duration remain relevant to benefit-risk assessment.

Regulatory status

Investigational in the reviewed sources.

Reported use & evidence

Research profile draft

The supplied Petrelintide profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds